baber/WOPTO huggingface dataset:
Patent AU-2004201802-B2 (AU)
Title: Secure communication with a keyboard or related device
Inventor: BENALOH JOSH
IPC: G06F21/00
Filed: 2004-04-29
Granted: 2010-01-21
Abstract: Secure communication between a keyboard and a component, such as a piece of software running on a computer. A first initial value is known to both the keyboard and the component. The keyboard and the component exchange nonces. The keyboard and the component each compute a second initial value and a third initial value based on the nonces and the first initial value. Both the keyboard and the component perform the same computation, so that the keyboard and the component each have the same second and third initial values. The keyboard encrypts keystrokes destined for the component using CBC-3DES based on the key and the second initial value, and also creates a message authentication code for each keystroke using CBC-3DESMAC based on the key and the third initial value. The component decrypts and verifies the keystrokes using the key and the second and third initial values.
Patent AU-2004218675-B2 (AU)
Title: Protein scaffolds for antibody mimics and other binding proteins
Inventor: LIPOVSEK DASA
IPC: C07K17/00
Filed: 2004-10-08
Granted: 2008-02-28
Abstract: Disclosed herein are proteins that include a fibronectin type III domain having at least one randomized loop. Also disclosed herein are nucleic acids encoding such proteins and the use of such proteins in methods for evolving novel compound-binding species and their ligands.
Patent AU-2004243014-B2 (AU)
Title: Stents with attached looped ends
Inventor: MOLLOY DEAN
IPC: A61F2/90
Filed: 2004-05-24
Granted: 2009-12-10
Abstract: An open frame prosthesis (16) is formed with looped end terminations (34,36,38,33) at both ends. At one end of the prosthesis, the filaments or strands are welded together in pairs to form strand couplings (46). A plurality of loop segments are connected to the strand couplings, one loop segment for each pair of adjacent strand couplings. Strands at the opposite end are bent to form looped ends (33). The loop segments can be connected to the couplings by welding, fusion bonds, or tubes, which are either crimped or heat shrunk.
Patent AU-2005202596-B2 (AU)
Title: Methods and compositions for inhibition of angiogenesis
Inventor: AMATO ROBERT J D
IPC: A61K31/192
Filed: 2005-06-15
Granted: 2009-10-22
Abstract: The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products have been shown to inhibit angiogenesis and to treat disease states resulting from angiogenesis. Additionally, anti-inflammatory drugs, such as steroids and NSAIDs can inhibit angiogenesis dependent diseases either alone or in combination with thalidomide and related compounds. Importantly, these compounds can be administered orally.
Patent AU-2005237267-B2 (AU)
Title: An ostomy appliance
Inventor: WORSOEE BJARNE
IPC: A61F5/441
Filed: 2005-05-03
Granted: 2010-10-07
Abstract: A collecting bag (8) for an ostomy appliance (2), said collecting bag (8) having a front wall (4) and a rear wall (6), the rear wall (6) having an opening through which waste material may enter the collecting bag (8), and wherein a manipulation pocket (10) is defined in the front (4) and/or the rear wall (6) of the collecting bag, said manipulation pocket (10) extending into the collecting bag and comprising transfer means (22) adapted to sealed transfer of mechanical movement from the surroundings to the interior of the collecting bag. The sealed transfer of movement can be used to open a passage inside the collecting bag such that flatus gasses may pass through a deodorizing filter, which prior to opening of the passage is protected such that it is not contaminated. Furthermore, the ostomy appliance comprises movement limiting means which limit the distance the transfer means may be moved.
Patent AU-2005282352-B2 (AU)
Title: Modulating phosphatase activity in cardiac cells
Inventor: FEDERICA DELMONTE
IPC: A61K31/66
Filed: 2005-09-08
Granted: 2011-12-01
Abstract: Expression of a phosphatase inhibitor in heart cells can be used to treat cardiac disorders, e.g., heart failure. Decreasing phosphatase activity can improve β-adrenergic responsiveness.
Patent AU-2005308060-B2 (AU)
Title: (S)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate
Inventor: OHSHIMA TAKESHI
IPC: A61K31/551
Filed: 2005-11-29
Granted: 2011-02-17
Abstract: The present invention is directed to (S)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate, to a method producing the dihydrate, and to a drug composition containing the dihydrate. The compound of the present invention has less hygroscopicity as compared with (S)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride anhydrous crystals and thus, exhibits excellent chemical stability.
Patent AU-2005317846-B2 (AU)
Title: Piperidine and azetidine derivatives as GlyT1 inhibitors
Inventor: ROBERT FLETCHER STEPHEN
IPC: C07D401/12
Filed: 2005-12-21
Granted: 2011-12-08
Abstract: The present invention provides compounds of formula (I), wherein both p's are one or two, R is generally heteroaryl or cycloalkyl, R is Ccycloalkyl or phenyl and R is heteroaryl, and pharmaceutically acceptable salts thereof, as GlyT1 inhibitors for treating schizophrenia, pharmaceutical compositions comprising the same and methods for their preparation.
Patent AU-2006202642-B2 (AU)
Title: Thin bladed obturator with curved surfaces
Inventor: THOMAS WENCHELL
IPC: A61B17/34
Filed: 2006-06-21
Granted: 2011-09-15
Abstract: THIN BLADED OBTURATOR WITH CURVED SURFACES Abstract A surgical obturator (100) includes an obturator member (104) having a distal end and a proximal end (192), and a blade member (200) adjacent the distal end of the s obturator member (104). The blade member (104) includes first and second surfaces (202) intersecting to define a peripheral cutting edge (204). At least one, preferably, both, of the first and second surfaces (202) is curved. At least one, preferably, both, of the first and second surfaces (202) is generally concave. The peripheral cutting edge (204) defined by the first and second intersecting surfaces (202) is substantially linear and 1o obliquely arranged with respect to the longitudinal axis of the obturator member (104). The peripheral cutting edge (204) may define an angle ranging from about 180 to 220 with respect to the longitudinal axis. Alternatively, the peripheral cutting edge (204) defined by the first and second surfaces (202) is generally arcuate, and may be concave or convex in configuration. In accordance with one preferred embodiment, the blade member (104) 15 includes opposed pairs of intersecting first and second surfaces (202), which define opposed peripheral cutting edges (204). The opposed peripheral cutting edges (204) extend to the penetrating end (206) of the blade member (104). A hollow grinding technique is employed to form the curved surfaces (202) and resulting cutting edges (204). Such technique provides significant benefits with respect to tissue resistance and 20 drag. Cc2
Patent AU-2006210029-B2 (AU)
Title: Permanent mould for casting light metal casting materials and use of said type of permanent mould and a casting material
Inventor: TRUEMPER JUERGEN
IPC: B22C9/06
Filed: 2006-01-27
Granted: 2010-02-18
Abstract: Cooling mold is dimensioned so that the heat expansion coefficient of the mold fits the heat expansion coefficient of the casting material to be cast made from nickel- and/or manganese-alloyed cast iron.
Patent AU-2006222283-B2 (AU)
Title: Growth factor mutants with improved biological activity
Inventor: PLOGER FRANK
IPC: A61K48/00
Filed: 2006-03-03
Granted: 2011-06-09
Abstract: The invention relates to novel biosynthetic growth factor mutants which exhibit improved biological activity.
Patent AU-2006238506-B2 (AU)
Title: Association between ferroquine and an artemisinine derivative for treating malaria
Inventor: TER-MINASSIAN DANIEL
IPC: A61P33/06
Filed: 2006-04-18
Granted: 2012-03-01
Abstract: The invention concerns a combination comprising ferroquine, in free base, salt, hydrate or solvate form, and an artemisinine derivative. The invention also concerns a pharmaceutical composition comprising ferroquine, in the form of one of its pharmaceutically acceptable salts, ferroquine hydrate or solvate, and at least one artemisinine derivative. The invention further concerns the use of such a combination for preparing a medicine for treating or preventing malaria. Finally, the invention concerns a kit for treating or preventing malaria.
Patent AU-2006265719-B2 (AU)
Title: Railway wheel sensor employing hall effect devices
Inventor: GLEN APPLEBY
IPC: B61L1/08
Filed: 2006-06-29
Granted: 2011-07-07
Abstract: A sensor for detecting the presence of wheels of a rail vehicle is disclosed. The sensor comprises first and second Hall Effect devices, a magnet for supplying a magnetic field to the first and second Hall Effect devices, means for mounting the first and second Hall Effect devices and the magnet adjacent to the rail, whereby a railway vehicle wheel changes the magnetic field in the Hall Effect devices to produce wheel indication signals, and a processing circuit for receiving the wheel indication signals from the first and second Hall Effect devices and for producing an output signal in response to the wheel indication signals. A method of detecting the presence of a wheel is also provided.
Patent AU-2006281334-B2 (AU)
Title: Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use of same
Inventor: SAUNAL HENRY
IPC: A61K31/437
Filed: 2006-07-27
Granted: 2012-10-18
Abstract: The invention relates to the combination of: a short-acting hypnotic agent which is selected from among a modulator of receptors GABA-A, a benzodiazepine, a phenothiazine, a melatonin derivative and a melatonin receptor agonist; and a long-acting hypnotic agent which is selected from among a modulator of receptors GABA-A, a benzodiazepine, an antagonist of receptors 5HT2A and a calcium ion modulator, for the treatment of sleep disorders. The invention also relates to galenic formulations containing said combination.
Patent AU-2006310555-B2 (AU)
Title: Prime boost vaccine for the protection of equines against equine influenza
Inventor: SASKIA DE ZANDE VAN
IPC: A61K39/145
Filed: 2006-10-27
Granted: 2011-08-04
Abstract: The present invention is concerned with vaccinating equines against the equine influenza virus (EIV). It has now been found that adequate protection against equine influenza in equines can be achieved when vaccination with a live equine influenza vaccine (prime) is followed by vaccination with an inactivated influenza vaccine (boost), wherein the two shots are given no longer than 8 weeks apart. The present invention therefore provides a method for vaccination of animals against equine influenza, wherein an animal is first vaccinated with a (prime) vaccine comprising an attenuated equine influenza virus, followed by a vaccination with a (boost) vaccine comprising an inactivated equine influenza virus, and wherein the boost vaccine is administered no longer than eight weeks after the prime vaccine. Preferably the two shots are given no longer than 8 weeks apart, for example, between 3-6 weeks apart, preferably between 4-6 weeks apart.
Patent AU-2006318131-B2 (AU)
Title: Compounds for the inhibition of apoptosis
Inventor: MAR ORZAEZ CALATAYUD
IPC: C07K5/087
Filed: 2006-11-22
Granted: 2011-07-21
Abstract: The present invention relates to compounds of formula (I) as well as to drug conjugates based on compounds of formula (I) acting as apoptosis inhibitors, as well as to processes for their preparation, to pharmaceutical compositions containing them and their use in medicine.
Patent AU-2006325228-B2 (AU)
Title: Immunoglobulins directed against NOGO
Inventor: GEORGE KOPSIDAS
IPC: A61P25/28
Filed: 2006-12-14
Granted: 2011-12-15
Abstract: The present invention relates to antibodies to NOGO, pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorder.
Patent AU-2006325907-B2 (AU)
Title: Fungicidal composition containing carboxylic acid amide derivative
Inventor: NAKAMURA YUJI
IPC: A01P3/00
Filed: 2006-12-13
Granted: 2012-05-17
Abstract: Conventional fungicidal compositions have had practical problems such that either a preventive effect or a curative effect is inadequate, the residual effect tends to be inadequate, or the controlling effect against plant diseases tends to be inadequate depending upon the application site, and a fungicidal composition to overcome such problems has been desired. The present invention provides a fungicidal composition containing a carboxylic acid amide derivative of the formula (I) or a salt thereof, as an active ingredient: wherein A is phenyl which may be substituted, benzodioxolanyl which may be substituted, or benzodioxanyl which may be substituted; B is 2- or 3-pyridyl which may be substituted; each of R and R is alkyl, or R and R may together form a 3- to 6-membered saturated carbon ring, provided that when B is 3-pyridyl which may be substituted, A is phenyl substituted by at least two substituents.
Patent AU-2006326256-B2 (AU)
Title: (2,5-dioxoimidazolidin-I-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors
Inventor: KEVIN PARKES
IPC: C07D233/76
Filed: 2006-12-13
Granted: 2011-11-03
Abstract: The invention provides compounds of the formula (I) wherein the variables are as defined in the specification. The compounds of the invention are inhibitors of metalloproteinase MMP-12 and are among other things useful for the treatment of obstructive airway diseases, such as chronic obstructive pulmonary disease (COPD).
Patent AU-2007243670-B2 (AU)
Title: Use of tetramic acid derivatives for controlling pests by drenching, drip application, dip application or soil injection
Inventor: RECKMANN UDO
IPC: A01N47/06
Filed: 2007-03-23
Granted: 2013-09-26
Abstract: Compounds of the formula (I) in which A, B, G, W, X, Y and Z can have the meanings given in the description are highly suitable for controlling animal pests such as insects and/or spider mites and/or nematodes by treating the soil/growth substrate by drenching or drip application or dipping or soil injection.
Patent AU-2007248738-B2 (AU)
Title: Nozzle interconnect
Inventor: THOMAS MITCHELL
IPC: B65B1/04
Filed: 2007-04-30
Granted: 2011-12-01
Abstract: An interconnect for a fuel dispensing nozzle which provides for sustained shut off of a nozzle when its spout is not inserted into the fill pipe of a fuel tank. When the spout inserts within the fill pipe its bellows or splashguard is forced rearwardly, for urging an interconnecting rod to move rearwardly, against the bias of a spring, to force a pivotal link to disengage from the automatic shut-off diaphragm, to allow it to function normally. But when the nozzle is removed from the fuel tank, the pivotal link contacts against the diaphragm structure, of the automatic shut-off, and prevents the nozzle from dispensing or delivering any fuel from the dispenser.
Patent AU-2007258694-B2 (AU)
Title: Administration of anti-CD3 antibodies in the treatment of autoimmune diseases
Inventor: PAUL PONATH
IPC: A61K39/395
Filed: 2007-06-05
Granted: 2011-12-22
Abstract: A method of treating an autoimmune disease, such as, diabetes or psoriasis, by administering an anti-CD3 antibody, or anti-CD3 antibody fragment. The anti-CD3 antibody, or anti-CD3 antibody fragment, is administered over a course of treatment wherein, during the course of treatment, the anti-CD3 antibody, or anti-CD3 antibody fragment is administered in a total amount which does not exceed 300 μg/kg when administered intravenously or, when administered other than intravenously, is administered in a total amount that does not exceed a total amount bioequivalent to 300μg/kg of intravenous administration thereof.
Patent AU-2007321701-B2 (AU)
Title: Use of tropoelastin for repair or restoration of tissue
Inventor: MITHIEUX SUZANNE MARIE
IPC: A61K8/64
Filed: 2007-11-13
Granted: 2012-08-30
Abstract: The present invention relates to tropoelastin and to tissue repair and restoration using elastic materials. Disclosed is a process for producing an elastic material from tropoelastin including heating a solution of tropoelastin having an alkaline pH to form an elastic material from the tropoelastin in the solution. Also disclosed are elastic materials prepared according to this process and their applications.
Patent AU-2007323924-B2 (AU)
Title: Bituminous emulsions
Inventor: STEPHENS KEITH E
IPC: E01C7/26
Filed: 2007-11-09
Granted: 2013-08-22
Abstract: The present invention is directed to bituminous emulsions comprising bitumen, water, one or more emulsifiers and a block copolymer composition.
Patent AU-2008229860-B2 (AU)
Title: Optimized Fc variants and methods for their generation
Inventor: KOHL DOBERSTEIN STEPHEN
IPC: C07K16/28
Filed: 2008-10-09
Granted: 2012-01-12
Abstract: P\OPER\HPM\Xncor\30663018\SpePagdoc-/10/2008 The present invention relates to optimized Fe variants, methods for their generation, and antibodies and Fc fusions comprising optimized Fc variants.
Patent AU-2008229964-B2 (AU)
Title: Universal joint
Inventor: MONDRAGON EDUARDO
IPC: F16D3/221
Filed: 2008-10-16
Granted: 2013-05-02
Abstract: Docket No.: DP-316668 (060408.00806) A universal joint includes an outer member defining an interior opening and a 5 plurality of grooves within the opening extending along a longitudinal axis. An inner member is disposed within the opening and includes a plurality of pockets opposing the grooves. A drive ball is disposed within each pocket and engages the opposing groove. Each of the pockets and each of the grooves opposing the pockets include a central axis passing through a ball center of the drive balls. The drive balls are supported by the 10 pockets and define a pocket contact angle. The drive balls are also supported by the grooves and define a groove contact angle. The pocket contact angle is less than the groove contact angle to urge the drive balls upward against the grooves. DP-316668 Delphi Technologies, Inc., Troy, MI C| C).
Patent AU-2008246281-B2 (AU)
Title: Connecting bar with flat interface
Inventor: BONFILS JEAN-MICHEL
IPC: H01R13/02
Filed: 2008-11-20
Granted: 2011-05-19
Abstract: The bar (10) has two connecting devices (12) including supports deformed and defined by two parallel opposite connecting surfaces. A high electrical conductivity connecting rod (34) connects conducting connection inserts of the connecting devices. The rod is integrated in the supports at its end parts (38) and integrated with an insulating coating at its residual part (42), where the supports and the coating are made of insulating material i.e. elastomer. Plane connecting interfaces provided among the supports, the inserts, the rod and the coating are sealed.
Patent AU-2008255329-B2 (AU)
Title: Magnesium-based alloy
Inventor: SHOKUROV VLADIMIR SERGEEVITCH
IPC: A61L15/00
Filed: 2008-05-05
Granted: 2011-04-07
Abstract: The present invention relates to compositions and structure of deformable alloys on the basis of magnesium with an optimum combination of mechanical properties (strength, plasticity) and a resistance to corrosion, including  in vivo . Alloys of the new group possess an excellent formability at room temperature, high corrosion stability in sodium chloride solution, excellent heat resistance and can be used in various technical applications, particularly  in vivo  as a structural material for stents. 
They comprise preferably indium, scandium, yttrium, rare earth metals and zirconium.
Patent AU-2008256767-B2 (AU)
Title: Method and device for quick press on EEG electrode
Inventor: JOHNSON DALE
IPC: A61B5/296
Filed: 2008-05-22
Granted: 2014-01-09
Abstract: Embodiments relate to methods and systems for monitoring bioelectric potentials. In some instances, an electrode is applied to a patient's skin. The electrode may be at least partly inserted into the patient's skin, such as by inserting at least part of one or more teeth underneath the skin.
Patent AU-2008258675-B2 (AU)
Title: Heatable humidifying device for use with tobacco products
Inventor: SUTTON JOSEPH PETER
IPC: A24F15/18
Filed: 2008-05-29
Granted: 2012-04-05
Abstract: A humidifier (10) for use with tobacco products comprises a first container (12) permeable to the passage of water vapour and configured to enclose a moisture-releasing element (14) that emits water vapour, a second container (18) arranged for thermal energy transfer to the moisture-releasing element, the second container having sealed therein a supercoolable salt hydrate solution and an activating device (22) actuable to initiate crystallisation of the salt hydrate solution, thereby releasing heat, and supplying it to the moisture-releasing element. The heating increases 'the rate of evaporation from the moisture-releasing element, thereby quickly providing water vapour to hydrate tobacco.
Patent AU-2008280820-B2 (AU)
Title: A block wall system
Inventor: CURRAN JAMIE CHRISTOPHER
IPC: E04C5/16
Filed: 2008-07-18
Granted: 2015-01-29
Abstract: A block wall system including a block wall having a multiplicity of courses of blocks; at least one longitudinal reinforcement bar that extends through the block wall; and at least one bracket for locating the longitudinal reinforcement bar; wherein the longitudinal reinforcement bar passes through the void of at least one block in the block wall and through a capture zone of the bracket located within the block wall.
Patent AU-2008290316-B2 (AU)
Title: Naked collation package
Inventor: MICHAEL JESCHKE
IPC: B32B27/32
Filed: 2008-08-04
Granted: 2011-09-29
Abstract: The invention is concerned with a naked collation package comprising an arrangement of individual packages, individually packaged in a polyolefinic filmic material, that are packed together in said naked collation package in a naked collation film, wherein the naked collation film comprises a sealable polyolefin film having a polyolefinic core layer C, an polyolefinic inner sealing layer A and a polyolefinic outer sealing layer B, the polyolefinic material of the inner sealing layer A being selected for sealing incompatibility with the filmic polyolefinic material of the individual packages under a specified sealing condition, and the polyolefinic material of the outer sealing layer B being selected for sealing compatibility with B and for sealing compatibility with A under the selected sealing condition, the individual packages being arranged in an ordered configuration inside the package and with the naked collation film wrapped around the ordered configuration of individual packages and sealed to itself (A to B) at a girth seal, and sealed to itself (B to B and optionally A to B) at envelope seals at each end of the package, there being no seal between the naked collation film and the filmic material of the individual packages.
Patent AU-2008294831-B2 (AU)
Title: Quenching vessel
Inventor: HEINEN HANS JOACHIM
IPC: B01D53/00
Filed: 2008-09-04
Granted: 2012-02-02
Abstract: Quenching vessel (1) being, in use, vertically elongated and provided with an inlet for gas (2) at its upper end, an outlet for cooled gas (3) at its lower end defining a pathway for a gas flow directed downwardly, the vessel being provided at its upper end with a first internal tubular wall part (5) which wall part has an opening fluidly connected to the inlet for gas and wherein tubular wall part is connected at its lower end with a divergent conical part (8) having walls which are inclined outwardly in the direction of the pathway for gas, wherein an arrangement of more than one nozzles (9) for atotnisation and spraying a liquid quench medium in a downward direction into the pathway for the gas flow are present in the space enclosed by the divergent conical part.